Successful treatment with modified CHOP-rituximab in pediatric AIDS-related advanced stage Burkitt lymphoma

Pediatric Blood and Cancer

Volumn 50, Issue 4, 2008, Pages 883-885

  Crosswell, Howland E ^a   Bergsagel, Daniel J ^b   Yost, Robert ^b   Lew, Glen ^b  

^a GREENVILLE HOSPITAL SYSTEM   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Burkitt lymphoma; HAART; HIV AIDS; Rituximab

Indexed keywords

ABACAVIR; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; HYDROCORTISONE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADVANCED CANCER; AIDS RELATED COMPLEX; ARTICLE; BURKITT LYMPHOMA; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CHROMOSOME ANALYSIS; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BURKITT LYMPHOMA; CHILD; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; PREDNISONE; VINCRISTINE;

EID: 40449106662     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21161     Document Type: Article

References (19)

1. Levine AM, Seneviratne L, Espina BM, et al. Evolving characteristics of AIDS-related lymphoma. Blood 2000;96:4084-4090.
2. Biggar RJ, Frisch M, Goedert JJ. Risk of cancer in children with aids. AIDS-cancer match registry study group. JAMA 2000;284:205-209.
3. Pollock BH, Jenson HB, Leach CT, et al. Risk factors for pediatric human immunodeficiency virus-related malignancy. JAMA 2003;289:2393-2399.
4. Link MP, Shuster JJ, Donaldson SS, et al. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med 1997;337:1259-1266.
5. Cairo MS, Sposto R, Perkins SL, et al. Burkitt's and Burkitt-like lymphoma in children and adolescents: A review of the children's cancer group experience. Br J Haematol 2003;120:660-670.
6. Boue F, Gabarre J, Gisselbrecht C, et al. Phase II trial of chop plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. J Clin Oncol 2006;24:4123-4128.
7. Coiffier B, Lepage E, Briere J, et al. Chop chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235-242.
8. Voigtlander C, Harrer T, Schneider L, et al. Diffuse large b-cell lymphoma on the back of a patient with aids: Successful treatment by the CD20 monoclonal antibody rituximab. Int J Dermatol 2005;44:976-978.
9. Spina M, Tirelli U. HIV-related non-Hodgkin's lymphoma (HIV-NHL) in the era of highly active antiretroviral therapy (HAART): Some still unanswered questions for clinical management. Ann Oncol 2004;15:993-995.
10. Antinori A, Cingolani A, Alba L, et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 2001;15:1483-1491.
11. Mounier N, Spina M, Gabarre J, et al. AIDS-related non-Hodgkin lymphoma: Final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood 2006;107:3832-3840.
12. Tirelli U, Spina M, Jaeger U, et al. Infusional cde with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: Preliminary results of a phase I/II study. Recent Results Cancer Res 2002;159:149-153.
13. Straus DJ. HIV-associated lymphoma: Promising new results, but with toxicity. Blood 2005;105:1842.
14. Kaplan LD, Lee JY, Ambinder RF, et al. Rituximab does not improve clinical outcome in a randomized phase 3 trial of chop with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-malignancies consortium trial 010. Blood 2005;106:1538-1543.
15. Spina M, Tirelli U. Rituximab for HIV-associated lymphoma: Weighing the benefits and risks. Curr Opin Oncol 2005;17:462-465.
16. Mounier N, Briere J, Gisselbrecht C, et al. Rituximab plus chop (r-chop) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (dlbcl). Blood 2003;101:4279-4284.
17. Manfredi N, Calza L, Chiodo F. Multiple AIDS-related malignancies just in the era of potent antiretroviral therapy. A rare but intriguing finding. Infez Med 2003;11:153-156.
18. Fluri S, Ammann R, Luthy AR, et al. High-dose therapy and autologous stem cell transplantation for children with HIV-associated non-Hodgkin lymphoma. Pediatr Blood Cancer 2006. E-pub ahead of print: 9 May 2006 DOI: 10.1002/pbc.20900.
19. Manfredi R, Tadolini M, Fortunato L, et al. Rituximab alone proves effective in the treatment of refractory, severe stage III AIDS-related non-Hodgkin's paediatric lymphoma. AIDS 2003;17:2146-2148.